indium has been researched along with Neuroendocrine Tumors in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Dimitriou, P; Dimitropoulos, N; Hatzioannou, A; Kontogeorgakos, D; Koutoulidis, V; Limouris, GS; Lyra, M; Mourikis, D; Papanikolos, G; Stravaka, A; Vlahos, L | 1 |
Bodei, L | 1 |
Abbas, K; Asim, S; Hussain, Z; Khan, NH; Naqvi, SAR; Usman, M; Yameen, M | 1 |
Bartenstein, P; Boening, G; Gosewisch, A; Ilhan, H; Lindner, S; Schirrmacher, R; Todica, A; Wängler, B; Wängler, C | 1 |
4 other study(ies) available for indium and Neuroendocrine Tumors
Article | Year |
---|---|
Evaluation of the therapeutic response to In-111-DTPA octreotide-based targeted therapy in liver metastatic neuroendocrine tumors according to CT/MRI/US findings.
Topics: Adult; Aged; DNA; Female; Humans; Indium; Indium Radioisotopes; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Male; Microscopy, Electron; Middle Aged; Neoplasm Metastasis; Neoplasms; Neuroendocrine Tumors; Octreotide; Pentetic Acid; Radionuclide Imaging; Tomography, X-Ray Computed; Ultrasonics; Ultrasonography | 2005 |
Somatostatin Receptor Scintigraphy: Blazing in Indium and Quenching in Gallium.
Topics: Gallium Radioisotopes; Humans; Indium Radioisotopes; Neuroendocrine Tumors; Radionuclide Imaging; Receptors, Somatostatin | 2020 |
Enzymatic degradation study of 111In-labeled minigastrin peptides using cathepsin B enzyme and AR42J cancer cell line for the development of neuroendocrine tumor imaging radiopharmaceuticals.
Topics: Animals; Cathepsin B; Cell Line, Tumor; Female; Gastrins; Indium Radioisotopes; Mice; Mice, Nude; Neuroendocrine Tumors; Peptide Fragments; Radiopharmaceuticals | 2018 |
First-in-human
Topics: Aged; Brachytherapy; Cell Proliferation; Fluorine Radioisotopes; Humans; Indium Radioisotopes; Liver Neoplasms; Male; Neoplasm Metastasis; Neuroendocrine Tumors; Peptides; Positron Emission Tomography Computed Tomography; Receptors, Peptide; Somatostatin; Theranostic Nanomedicine | 2019 |